首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice.
【24h】

Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice.

机译:在高脂饮食诱导的肥胖小鼠中,通过桑叶,梅利莎草和青蒿的草药提取物对肥胖和脂质疾病的调节。

获取原文
获取原文并翻译 | 示例
           

摘要

Melissa officinalis L. (Labiatae), Morus alba L. (Moraceae), and Artemisia capillaris Thunb. (Compositae) are suggested to be involved in the regulation of hyperlipidemia. We hypothesized that Ob-X, a mixture of three herbs, Morus alba, Melissa officinalis and Artemisia iwayomogi, improves lipid metabolism, body weight gain and adiposity and that peroxisome proliferator-activated receptor alpha (PPARalpha) is associated with these events. Mice fed a high-fat diet for 12 weeks exhibited increases in body weight gain and adipose tissue mass compared with mice fed a low fat diet. However, feeding a high-fat diet supplemented with Ob-X significantly reduced these effects. Ob-X treatment also decreased the circulating levels of triglycerides and total cholesterol, and inhibited hepatic lipid accumulation. Ob-X supplementation was found to increase the hepatic mRNA levels of PPARalpha target enzymes responsible for fatty acid beta-oxidation. Moreover, Ob-X elevated the endogenous expression of a luciferase reporter gene containing three copies of a PPAR response element (PPRE) in NMu2Li liver cells. These data demonstrate that Ob-X regulates body weight gain, adipose tissue mass, and lipid metabolism in part through changes in the expression of hepatic PPARalpha target genes.
机译:Melissa officinalis L.(Labiatae),Morus alba L.(Moraceae)和Artemisia capillaris Thunb。 (菊科)被建议参与高脂血症的调节。我们假设Ob-X是三种桑树,桑叶梅利莎和艾蒿的混合物,可改善脂质代谢,体重增加和肥胖,并且过氧化物酶体增殖物激活受体α(PPARalpha)与这些事件有关。与低脂饮食喂养的小鼠相比,高脂饮食喂养12周的小鼠体重增加和脂肪组织质量增加。但是,饲喂补充有Ob-X的高脂饮食会明显降低这些影响。 Ob-X治疗还降低了甘油三酸酯和总胆固醇的循环水平,并抑制了肝脂质的积累。发现Ob-X补充会增加负责脂肪酸β-氧化的PPARalpha目标酶的肝mRNA水平。此外,Ob-X在NMu2Li肝细胞中提高了荧光素酶报告基因的内源性表达,该基因包含三份PPAR反应元件(PPRE)。这些数据表明,Ob-X部分通过肝脏PPARalpha靶基因表达的变化来调节体重增加,脂肪组织质量和脂质代谢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号